Aminopeptidase N (APN)/CD13-dependent CXCR4 downregulation is associated with diminished cell migration, proliferation and invasion

References

• Ashmun RA, Shapiro LH, Look AT. Deletion of the zinc-binding motif of CD13/aminopeptidase N molecules results in loss of epitopes that mediate binding of inhibitory antibodies. Blood 1992; 79: 3344–3349
   Google Scholar
• Bauvois B. Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis?. Oncogene 2004; 23: 317–329
   PubMed Web of Science ®Google Scholar
• Bauvois B, Dauzonne D. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects. Med Res Rev 2006; 26: 88–130
   PubMed Web of Science ®Google Scholar
• Bhagwat SV, Lahdenranta J, Giordano R, Arap W, Pasqualini R, Shapiro LH. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood 2001; 97: 652–659
   PubMed Web of Science ®Google Scholar
• Bogenrieder T, Finstad CL, Freeman RH, Papandreou CN, Scher HI, Albino AP, Reuter VE, Nanus DM. Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue. Prostate 1997; 33: 225–232
   PubMed Web of Science ®Google Scholar
• Carl-McGrath S, Lendeckel U, Ebert M, Wolter AB, Roessner A, Rocken C. The ectopeptidases CD10, CD13, CD26, and CD143 are upregulated in gastric cancer. Int J Oncol 2004; 25: 1223–1232
   PubMed Web of Science ®Google Scholar
• Courtenay VD. A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouse. Br J Cancer 1976; 34: 39–45
   PubMedGoogle Scholar
• Delmas B, Gelfi J, L'Haridon R, Vogel LK, Sjostrom H, Noren O, Laude H. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature 1992; 357: 417–420
   PubMed Web of Science ®Google Scholar
• Diodovich C, Malerba I, Ferrario D, Bowe G, Bianchi MG, Acquati F, Taramelli R, Parent-Massin D, Gribaldo L. Gene and protein expressions in human cord blood cells after exposure to acrylonitrile. J Biochem Mol Toxicol 2005; 19: 204–212
   PubMed Web of Science ®Google Scholar
• Dybkaer K, Olesen G, Pedersen FS, Kristensen JS. Stromal-mediated down-regulation of CD13 in bone marrow cells originating from acute myeloid leukemia patients. Eur J Haematol 2001; 66: 168–177
   PubMed Web of Science ®Google Scholar
• Firla B, Arndt M, Frank K, Thiel U, Ansorge S, Tager M, Lendeckel U. Extracellular cysteines define ectopeptidase (APN, CD13) expression and function. Free Radic Biol Med 2002; 32: 584–595
   Google Scholar
• Fujii H, Nakajima M, Saiki I, Yoneda J, Azuma I, Tsuruo T. Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13. Clin Exp Metastasis 1995; 13: 337–344
   Google Scholar
• Fukasawa K, Fukasawa KM, Iwamoto H, Hirose J, Harada M. The HELLGH motif of rat liver dipeptidyl peptidase III is involved in zinc coordination and the catalytic activity of the enzyme. Biochemistry 1999; 38: 8299–8303
   Google Scholar
• Gabrilovac J, Cupic B, Breljak D, Zekusic M, Boranic M. Expression of CD13/aminopeptidase N and CD10/neutral endopeptidase on cultured human keratinocytes. Immunol Lett 2004; 91: 39–47
   PubMed Web of Science ®Google Scholar
• Gohring B, Holzhausen HJ, Meye A, Heynemann H, Rebmann U, Langner J, Riemann D. Endopeptidase 24.11/CD10 is down-regulated in renal cell cancer. Int J Mol Med 1998; 2: 409–414
   Google Scholar
• Hooper NM. Families of zinc metalloproteases. FEBS Lett 1994; 354: 1–6
   PubMed Web of Science ®Google Scholar
• Ikeda N, Nakajima Y, Tokuhara T, Hattori N, Sho M, Kanehiro H, Miyake M. Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma. Clin Cancer Res 2003; 9: 1503–1508
   PubMed Web of Science ®Google Scholar
• Kawamura J, Shimada Y, Kitaichi H, Komoto I, Hashimoto Y, Kaganoi J, Miyake M, Yamasaki S, Kondo K, Imamura M. Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma. Hepatogastroenterology 2007; 54: 36–40
   Google Scholar
• Kehlen A, Englert N, Seifert A, Klonisch T, Dralle H, Langner J, Hoang-Vu C. Expression, regulation and function of autotaxin in thyroid carcinomas. Int J Cancer 2004; 109: 833–838
   PubMed Web of Science ®Google Scholar
• Kehlen A, Lendeckel U, Dralle H, Langner J, Hoang-Vu C. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas. Cancer Res 2003; 63: 8500–8506
   PubMed Web of Science ®Google Scholar
• Kido A, Krueger S, Haeckel C, Roessner A. Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells. Clin Exp Metastasis 2003; 20: 585–592
   Google Scholar
• Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, Ratajczak MZ. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 2004; 35: 233–245
   PubMed Web of Science ®Google Scholar
• Kumano N, Sugawara S. Ubenimex (Bestatin), an aminopeptidase inhibitor, modulates protein kinase C in K562 cells. J Biol Regul Homeost Agents 1992; 6: 116–120
   Google Scholar
• Larsen SL, Pedersen LO, Buus S, Stryhn A. T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides. J Exp Med 1996; 184: 183–189
   PubMed Web of Science ®Google Scholar
• Laustsen PG, Vang S, Kristensen T. Mutational analysis of the active site of human insulin-regulated aminopeptidase. Eur J Biochem 2001; 268: 98–104
   Google Scholar
• Lee VH. Membrane transporters. Eur J Pharm Sci 11 Suppl 2000; 2: S41–50
   Google Scholar
• Look AT, Ashmun RA, Shapiro LH, Peiper SC. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest 1989; 83: 1299–1307
   PubMed Web of Science ®Google Scholar
• Luciani N, Marie-Claire C, Ruffet E, Beaumont A, Roques BP, Fournie-Zaluski MC. Characterization of Glu350 as a critical residue involved in the N-terminal amine binding site of aminopeptidase N (EC 3.4.11.2): insights into its mechanism of action. Biochemistry 1998; 37: 686–692
   PubMed Web of Science ®Google Scholar
• Marotti T, Balog T, Munic V, Sobocanec S, Abramic M. The link between met-enkephalin-induced down-regulation of APN activity and the release of superoxide anion. Neuropeptides 2000; 34: 121–128
   PubMedGoogle Scholar
• Murata M, Kubota Y, Tanaka T, Iida-Tanaka K, Takahara J, Irino S. Effect of ubenimex on the proliferation and differentiation of U937 human histiocytic lymphoma cells. Leukemia 1994; 8: 2188–2193
   Google Scholar
• Petrovic N, Schacke W, Gahagan JR, O'Conor C A, Winnicka B, Conway RE, Mina-Osorio P, Shapiro LH. CD13/APN regulates endothelial invasion and filopodia formation. Blood 2007; 110: 142–150
   PubMed Web of Science ®Google Scholar
• Proost P, Mortier A, Loos T, Vandercappellen J, Gouwy M, Ronsse I, Schutyser E, Put W, Parmentier M, Struyf S, Van Damme J. Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signalling and reduces lymphocyte and endothelial cell migration. Blood 2007; 110: 37–44
   Google Scholar
• Riemann D, Blosz T, Wulfaenger J, Navarrete Santos A. Signal transduction via membrane peptidases. Ectopeptidases, J Langner, S Ansorge. Academic/Plenum Publishers, New York 2002; 141–170
   Google Scholar
• Riemann D, Kehlen A, Langner J. CD13–not just a marker in leukemia typing. Immunol Today 1999; 20: 83–88
   Google Scholar
• Rocken C, Carl-McGrath S, Grantzdorffer I, Mantke R, Roessner A, Lendeckel U. Ectopeptidases are differentially expressed in hepatocellular carcinomas. Int J Oncol 2004; 24: 487–495
   Web of Science ®Google Scholar
• Santos AN, Langner J, Herrmann M, Riemann D. Aminopeptidase N/CD13 is directly linked to signal transduction pathways in monocytes. Cell Immunol 2000; 201: 22–32
   PubMedGoogle Scholar
• Shioda T, Kato H, Ohnishi Y, Tashiro K, Ikegawa M, Nakayama EE, Hu H, Kato A, Sakai Y, Liu H, Honjo T, Nomoto A, Iwamoto A, Morimoto C, Nagai Y. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc Natl Acad Sci USA 1998; 95: 6331–6336
   PubMed Web of Science ®Google Scholar
• Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76–85
   PubMed Web of Science ®Google Scholar
• Soderberg C, Giugni TD, Zaia JA, Larsson S, Wahlberg JM, Moller E. CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol 1993; 67: 6576–6585
   PubMedGoogle Scholar
• Tieku S, Hooper NM. Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme. Biochem Pharmacol 1992; 44: 1725–1730
   Google Scholar
• Turner AJ. Membrane alanyl aminopeptidase. Handbook of proteolytic enzymes, AJ Barrett, ND Rawlings, JF Woessner. Academic Press, London 1998; 996–1000
   Google Scholar
• Vallee BL, Auld DS. Zinc coordination, function, and structure of zinc enzymes and other proteins. Biochemistry 1990; 29: 5647–5659
   PubMed Web of Science ®Google Scholar
• van Hensbergen Y, Broxterman HJ, Rana S, van Diest PJ, Duyndam MC, Hoekman K, Pinedo HM, Boven E. Reduced growth, increased vascular area, and reduced response to cisplatin in CD13-overexpressing human ovarian cancer xenografts. Clin Cancer Res 2004; 10: 1180–1191
   Google Scholar
• Vazeux G, Wang J, Corvol P, Llorens-Cortes C. Identification of glutamate residues essential for catalytic activity and zinc coordination in aminopeptidase A. J Biol Chem 1996; 271: 9069–9074
   Google Scholar
• Xu Y, Wellner D, Scheinberg DA. Substance P and bradykinin are natural inhibitors of CD13/aminopeptidase N. Biochem Biophys Res Commun 1995; 208: 664–674
   Google Scholar
• Yeager CL, Ashmun RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT, Holmes KV. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 1992; 357: 420–422
   PubMed Web of Science ®Google Scholar
• Zhang N, Hodge D, Rogers TJ, Oppenheim JJ. Ca2 + -independent protein kinase Cs mediate heterologous desensitization of leukocyte chemokine receptors by opioid receptors. J Biol Chem 2003; 278: 12729–12736
   Google Scholar